Zbigniew Markowski - HELIX BIOPHARMA CEO
HBP Stock | EUR 0.12 0.02 14.29% |
CEO
Dr. Zbigniew Markowski is Chief Executive Officer of the Company. Dr. Markowski comes with a diversified experience having had a career in business university and government. Among others from 2006 until January 10 2016 he served as Chairman of O.M. Finance Ltd a private investment and consulting company from 1998 to 2002 as vicechairman of Prokom Investments SA a Polish investment fund where he was responsible for the financial and pharmaceutical sectors and as Member of the Board of BIOTON SA a pharmaceutical company listed on the Warsaw Stock Exchange from 1993 to 2005 he was a leading coordinator for more than a dozen initial public offerings of Polish companies listed on the WSE. From 1995 he was member or Chairman of the Supervisory Board of many companies listed on the WSE and additionally he served as chairman of the Audit Committees of CIECH SA II NFI SA and ROBYG SA.In 1993 he served as Special Plenipotentiary to the Minister of Privatization and to the Minister of Foreign Trade and in 1994 he was appointed as Commercial Counselor of the Polish People Republic in Stockholm Sweden since 2016.
Tenure | 8 years |
Professional Marks | Ph.D |
HELIX BIOPHARMA Leadership Team
Elected by the shareholders, the HELIX BIOPHARMA's board of directors comprises two types of representatives: HELIX BIOPHARMA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of HELIX. The board's role is to monitor HELIX BIOPHARMA's management team and ensure that shareholders' interests are well served. HELIX BIOPHARMA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, HELIX BIOPHARMA's outside directors are responsible for providing unbiased perspectives on the board's policies.
Albert Beraldo, Director | ||
Artur Gabor, Independent Director | ||
Steve Demas, COO | ||
Marek Orlowski, Independent Director | ||
Slawomir Majewski, Independent Chairman of the Board | ||
George Anders, Director | ||
Ireneusz Fafara, Independent Director | ||
Heman Chao, Chief Executive Officer, Chief Scientific Officer, Director | ||
Theordore Witek, Director | ||
Zbigniew Markowski, CEO | ||
Sylwester Cacek, Director | ||
Sven Rohmann, Chairman of the Board | ||
Photios Michalargias, Chief Financial Officer | ||
Patrick Frankham, COO |
HELIX Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is HELIX BIOPHARMA a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Current Valuation | 29.03 M | |||
Price To Book | 129.78 X | |||
EBITDA | (6.53 M) | |||
Net Income | (6.56 M) | |||
Cash Flow From Operations | (6.51 M) | |||
Number Of Employees | 14 | |||
Market Capitalization | 38.94 M | |||
Total Asset | 3.73 M | |||
Z Score | -3.3 | |||
Net Asset | 3.73 M |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards HELIX BIOPHARMA in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, HELIX BIOPHARMA's short interest history, or implied volatility extrapolated from HELIX BIOPHARMA options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in HELIX BIOPHARMA. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Complementary Tools for HELIX Stock analysis
When running HELIX BIOPHARMA's price analysis, check to measure HELIX BIOPHARMA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HELIX BIOPHARMA is operating at the current time. Most of HELIX BIOPHARMA's value examination focuses on studying past and present price action to predict the probability of HELIX BIOPHARMA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HELIX BIOPHARMA's price. Additionally, you may evaluate how the addition of HELIX BIOPHARMA to your portfolios can decrease your overall portfolio volatility.
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Stocks Directory Find actively traded stocks across global markets | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |